Literature DB >> 9679082

Evidence for growth hormone/insulin-like growth factor I axis regulation of seawater acclimation in the euryhaline teleost Fundulus heteroclitus.

J M Mancera1, S D McCormick.   

Abstract

The ability of ovine growth hormone (oGH), recombinant bovine insulin-like growth factor I (rbIGF-I), recombinant human insulin-like growth factor II (rhIGF-II), and bovine insulin to increase hypoosmoregulatory capacity in the euryhaline teleost Fundulus heteroclitus was examined. Fish acclimated to brackish water (BW, 10 ppt salinity, 320 mOsm/kg H2O) were injected with a single dose of hormone and transferred to seawater (SW, 35 ppt salinity, 1120 mOsm/kg H2O) 2 days later. Fish were sampled 24 h after transfer and plasma osmolality, plasma glucose, and gill Na+, K+-ATPase activity were examined. Transfer from BW to SW increased plasma osmolality and gill Na+,K+-ATPase activity. Transfer from BW to BW had no effect on these parameters. rbIGF-I (0.05, 0.1, and 0.2 microg/g) improved the ability to maintain plasma osmolality and to increase gill Na+, K+-ATPase activity in a dose-dependent manner. oGH (0.5, 1, and 2 microg/g) also increased hypoosmoregulatory ability but only the higher doses (2 microg/g) significantly increased gill Na+,K+-ATPase activity. oGH (1 microg/g) and rbIGF-I (0.1 microg/g) had a significantly greater effect on plasma osmolality and gill Na+,K+-ATPase activity than either hormone alone. rhIGF-II (0.05, 0.1, and 0.2 microg/g) and bovine insulin (0.01 and 0.05 microg/g) were without effect. The results suggest a role of GH and insulin-like growth factor I (IGF-I) in seawater acclimation of F. heteroclitus. Based on these findings and previous studies, it is concluded that the capacity of the GH/IGF-I axis to increase hypoosmoregulatory ability may be a common feature of euryhalinity in teleosts. Copyright 1998 Academic Press.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9679082     DOI: 10.1006/gcen.1998.7086

Source DB:  PubMed          Journal:  Gen Comp Endocrinol        ISSN: 0016-6480            Impact factor:   2.822


  6 in total

1.  Growth hormone transgenesis affects osmoregulation and energy metabolism in zebrafish (Danio rerio).

Authors:  Daniela Volcan Almeida; Camila de Martinez Gaspar Martins; Márcio de Azevedo Figueiredo; Carlos Frederico Ceccon Lanes; Adalto Bianchini; Luis Fernando Marins
Journal:  Transgenic Res       Date:  2012-06-19       Impact factor: 2.788

2.  Phosphorylation state of the Na+-K+-Cl- cotransporter (NKCC1) in the gills of Atlantic killifish (Fundulus heteroclitus) during acclimation to water of varying salinity.

Authors:  Andreas W Flemmer; Michelle Y Monette; Maja Djurisic; Brian Dowd; Rachel Darman; Ignacio Gimenez; Biff Forbush
Journal:  J Exp Biol       Date:  2010-05       Impact factor: 3.312

3.  Discovery of prolactin-like in lamprey: Role in osmoregulation and new insight into the evolution of the growth hormone/prolactin family.

Authors:  Ningping Gong; Diogo Ferreira-Martins; Jessica L Norstog; Stephen D McCormick; Mark A Sheridan
Journal:  Proc Natl Acad Sci U S A       Date:  2022-09-26       Impact factor: 12.779

4.  Control of leptin by metabolic state and its regulatory interactions with pituitary growth hormone and hepatic growth hormone receptors and insulin like growth factors in the tilapia (Oreochromis mossambicus).

Authors:  Jonathan D Douros; David A Baltzegar; Jamie Mankiewicz; Jordan Taylor; Yoko Yamaguchi; Darren T Lerner; Andre P Seale; E Gordon Grau; Jason P Breves; Russell J Borski
Journal:  Gen Comp Endocrinol       Date:  2016-07-19       Impact factor: 2.822

5.  Gene encoding prolactin in cinnamon clownfish Amphiprion melanopus and its expression upon acclimation to low salinities.

Authors:  Gyeong Eon Noh; Sum Rho; Yong Jin Chang; Byung Hwa Min; Jong-Myoung Kim
Journal:  Aquat Biosyst       Date:  2013-01-01

6.  Activities of Amphioxus GH-Like Protein in Osmoregulation: Insight into Origin of Vertebrate GH Family.

Authors:  Mengyang Li; Chengyan Jiang; Yu Zhang; Shicui Zhang
Journal:  Int J Endocrinol       Date:  2017-03-17       Impact factor: 3.257

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.